Cathay Biotech Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Cathay Biotech has a total shareholder equity of CN¥15.0B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 8.7%. Its total assets and total liabilities are CN¥18.3B and CN¥3.3B respectively. Cathay Biotech's EBIT is CN¥316.0M making its interest coverage ratio -2.4. It has cash and short-term investments of CN¥4.6B.
Belangrijke informatie
8.7%
Verhouding schuld/eigen vermogen
CN¥1.30b
Schuld
| Rente dekkingsratio | -2.4x |
| Contant | CN¥4.64b |
| Aandelen | CN¥14.99b |
| Totaal verplichtingen | CN¥3.34b |
| Totaal activa | CN¥18.33b |
Recente financiële gezondheidsupdates
Cathay Biotech (SHSE:688065) Seems To Use Debt Quite Sensibly
Sep 29
Cathay Biotech (SHSE:688065) Has A Somewhat Strained Balance Sheet
May 28Recent updates
What Cathay Biotech Inc.'s (SHSE:688065) 38% Share Price Gain Is Not Telling You
Oct 22Cathay Biotech (SHSE:688065) Could Be Struggling To Allocate Capital
Oct 20Cathay Biotech (SHSE:688065) Seems To Use Debt Quite Sensibly
Sep 29Cathay Biotech Inc.'s (SHSE:688065) Share Price Not Quite Adding Up
Sep 07There Are Reasons To Feel Uneasy About Cathay Biotech's (SHSE:688065) Returns On Capital
Jun 19Cathay Biotech (SHSE:688065) Has A Somewhat Strained Balance Sheet
May 28What Cathay Biotech Inc.'s (SHSE:688065) 27% Share Price Gain Is Not Telling You
May 07We Think That There Are More Issues For Cathay Biotech (SHSE:688065) Than Just Sluggish Earnings
May 06Analyse van de financiële positie
Kortlopende schulden: 688065's short term assets (CN¥6.8B) exceed its short term liabilities (CN¥2.4B).
Langlopende schulden: 688065's short term assets (CN¥6.8B) exceed its long term liabilities (CN¥966.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 688065 has more cash than its total debt.
Schuld verminderen: 688065's debt to equity ratio has increased from 6% to 8.7% over the past 5 years.
Schuldendekking: 688065's debt is well covered by operating cash flow (55.1%).
Rentedekking: 688065 earns more interest than it pays, so coverage of interest payments is not a concern.